0
0
A comprehensive new study from Denmark spanning 24 years has found no evidence that aluminium salts in childhood vaccines increase the risk of developing conditions such as asthma, autism, or a host of other autoimmune and neurodevelopmental disorders. The investigation, which tracked more than 1.2 million children, provides robust reassurance against claims that aluminium used in vaccines poses a significant health danger to children.
Aluminium salts, used for over 70 years as adjuvants to enhance the immune response to vaccines, have been central to debate and concern among some parents and vaccine critics. The large nationwide cohort study specifically examined whether cumulative aluminium exposure from routine childhood vaccinations correlated with higher rates of 50 different conditions, including autoimmune, allergic, and neurodevelopmental disorders. The results were striking: not one of these conditions occurred at rates above what would be expected in the general population.
Senior author Anders Hviid, head of epidemiology research at Denmark’s Statens Serum Institut, described the findings as “quite striking,” stating, “We should not be concerned about aluminium used as an adjuvant in childhood vaccines. I think that’s the core message”. The safety of aluminium adjuvants, the study suggests, can be affirmed with a high degree of certainty for these outcomes.
Aluminium is commonly found in inactivated (killed-virus or protein-based) vaccines and is not present in live-attenuated or mRNA vaccines such as the MMR (measles, mumps, rubella) or most COVID-19 vaccines1. While the total amount of aluminium children receive from vaccines remains far below established safety thresholds, the debate has persisted over possible links to childhood disorders—especially autism and asthma. This latest research follows international expert recommendations for further study and directly counters anti-vaccine narratives by providing large-scale, real-world evidence.
Other independent studies have repeatedly found no causal relationship between aluminium adjuvants and autism or allergies, and governmental bodies such as the CDC and FDA continue to monitor vaccine safety worldwide.
“Aluminium used to make vaccines more effective does not make them more dangerous,” the researchers conclude.
Disclaimer: This article summarizes current scientific findings from a major Danish cohort study and is intended for informational purposes only. It does not constitute medical advice. For individual health concerns and vaccination decisions, please consult a qualified healthcare professional.
